Αποτελέσματα Αναζήτησης
18 Οκτ 2021 · It is important to make a clinical decision about how to treat the person with diabetes. Regardless of any features of type 2 diabetes or absence of islet antibodies, if there is a clinical suspicion of type 1 diabetes, the individual should be treated with insulin.
25 Φεβ 2015 · New guideline sections on: Determining diabetes type. Management of hypoglycemia. Non-insulin options for patients with insulin resistance and type 1 diabetes. Expanded content on dietary recommendations. Prevention.
Type 1 diabetes is a condition caused by autoimmune damage of the insulin-producing beta cells of the pancreatic islets, usually leading to severe endogenous insulin deficiency. Type 1 diabetes accounts for approximately 5 –10% of all cases of diabetes.
30 Σεπ 2021 · This seminal study has been the basis for glycaemic target recommendations for type 1 diabetes worldwide. The cost of intensive management was, however, a 2–3-fold increase in the rates of severe hypoglycaemia, as well as weight gain.
1 Ιαν 2021 · CGM serves an important role in assessing the effectiveness and safety of treatment in many patients with type 1 diabetes, including prevention of hypoglycemia, and in patients with type 2 diabetes on intensive insulin regimens and with hypoglycemia.
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
12 Δεκ 2022 · In people with type 1 diabetes, treatment with analog insulins is associated with less hypoglycemia and weight gain as well as lower A1C compared with human insulins (6–8). More recently, two injectable insulin formulations with enhanced rapid-action profiles have been introduced.
